Valuation: Acutaas Chemicals Limited

Market Cap 263B 2.78B 2.48B 2.29B 2.08B 3.9B 3.96B 27.57B 10.86B 138B 10.43B 10.21B 437B P/E 2027 *
57.9x
P/E 2028 * 42.5x
Enterprise Value 259B 2.74B 2.44B 2.25B 2.05B 3.84B 3.9B 27.15B 10.7B 136B 10.27B 10.05B 430B EV / Sales 2027 *
14.5x
EV / Sales 2028 * 10.8x
Free-Float
61.69%
Yield 2027 *
0.1%
Yield 2028 * 0.13%
1 day+2.00%
1 week+2.64%
Current month-1.95%
1 month+0.05%
3 months-12.14%
6 months+32.69%
Current year+88.59%
1 week 3,100
Extreme 3100
3,354.4
1 month 3,031.1
Extreme 3031.1
3,366.6
Current year 1,570
Extreme 1570
3,740
1 year 1,570
Extreme 1570
3,740
3 years 502.22
Extreme 502.225
3,740
5 years 383.05
Extreme 383.05
3,740
10 years 383.05
Extreme 383.05
3,740
Manager TitleAgeSince
Chief Executive Officer 52 2007-07-11
Director of Finance/CFO 48 2022-05-31
Chief Operating Officer - 2026-07-01
Director TitleAgeSince
Chairman 52 2007-07-11
Director/Board Member 52 2007-07-11
Director/Board Member 65 2018-04-22
Date Insider Type Main position Quantity % Market Cap. Importance
1/6/25 Buy

Director

2,000 0.0049%
1/6/25 Sell

Director

400 0.0010%
9/17/24 Sell 25,000 0.0611%
Change 5-day change 1-year change 3-year change Capi.($)
+2.00%+2.64%+79.77%+436.60% 2.78B
+0.38%-2.54%+18.90%+36.92% 68.66B
+0.71%-0.88%+20.70%+28.93% 50.51B
+0.44%-1.00%-1.94%+26.56% 15.92B
-0.94%-1.68%+29.88%+73.13% 13.62B
+6.90%+7.06%+194.96%+12.92% 10.93B
+0.82%-3.87%+23.95%-8.22% 10.03B
-0.94%-4.35%+30.43%+30.98% 9.7B
+0.71%-4.07%+8.55% - 8.81B
-1.20%-6.37%-24.91%+6.26% 7.31B
Average +0.89%-0.58%+38.03%+71.56% 19.83B
Weighted average by Cap. +0.68%-1.19%+27.74%+37.13%

Financials

2027 *2028 *
Net sales 17.83B 188M 168M 155M 141M 264M 268M 1.87B 736M 9.34B 707M 691M 29.59B 23.79B 251M 224M 207M 188M 353M 358M 2.49B 982M 12.47B 943M 923M 39.49B
Net income 4.55B 48.01M 42.85M 39.53M 35.92M 67.38M 68.42M 476M 188M 2.38B 180M 176M 7.55B 6.19B 65.34M 58.32M 53.8M 48.88M 91.7M 93.11M 648M 255M 3.24B 245M 240M 10.27B
Net Debt -3.97B -41.86M -37.37M -34.47M -31.32M -58.76M -59.66M -415M -164M -2.08B -157M -154M -6.58B -6.65B -70.16M -62.63M -57.78M -52.49M -98.47M -99.99M -696M -274M -3.48B -263M -258M -11.03B
Projected Income Statement - Annual - Acutaas Chemicals Limited
Logo Acutaas Chemicals Limited
Acutaas Chemicals Limited, formerly Ami Organics Limited, is an India-based company, which is engaged in the manufacturing of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 610 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas.
Employees
1,007
Date Price Change Volume
26-10-22 ₹3,215.30 +2.00% 309,343
26-10-21 ₹3,152.40 -3.10% 304,749
26-10-19 ₹3,253.40 +1.48% 557,451
26-10-16 ₹3,206.00 +2.35% 482,617
26-10-15 ₹3,132.50 -0.89% 211,008
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Acutaas Chemicals Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
3,215.30INR
Average target price
3,324.78INR
Spread / Average Target
+3.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Acutaas Chemicals Limited
  1. Stock Market
  2. Stocks
  3. ACUTAAS Stock